The patient gene therapy journey

Gene therapies for both haemophilia A and B are currently in development. Although this is ongoing, the first gene therapy for haemophilia A has been given conditional market authorisation in Europe – which means it could be more widely available as a treatment option soon. Gene therapies for haemophilia aim to replace the faulty, disease-causing …

Read more